Artrite Reumatoide

Osteoporosi Maschile




1. Franceschi C, Olivieri F, Colonna-Romano G, et al.
Allele frequencies of +874T->A single nucleotide polymorphism
at the first intron of interferon-gamma gene in a group of Italian
centenarians. Lio D, Scola L, Crivello A, Bonafe M. Exp
Gerontol 2002 Jan 3;37(2-3):315-319.

2. Eckstein F, Lochmuller EM, Lill CA, et al.
Bone strength at clinically relevant sites displays substantial
heterogeneity and is best predicted from site-specific bone
densitometry. J Bone Miner Res 2002 Jan;17(1):162-71.

3. Ringe JD, Rovati LC.
Treatment of osteoporosis in men with fluoride a
lone or in
combination with bisphosphonates. Calcif Tissue Int 2001

4. Bilezikian JP, Kurland ES.
Therapy of male osteoporosis with parathyroid hormone. Calcif
Tissue Int 2001 Oct;69(4):248-51.

5. Francis RM.
Androgen replacement in aging men. Calcif Tissue Int 2001

6. Wuster C, Hadji P.
Use of quantitative ultrasound densitometry (QUS) in male
osteoporosis. Calcif Tissue Int 2001 Oct;69(4):225-8.

7. Lombardi A, Ross PD.
The assessment of bone mass in men. Calcif Tissue Int 2001

8. Audran M, Chappard D, Legrand E, et al.
Bone microarchitecture and bone fragility in men: DXA and
histomorphometry in humans and in the orchidectomized rat
model. Calcif Tissue Int 2001 Oct;69(4):214-7.

9. Chavassieux P, Meunier PJ.
Histomorphometric approach of bone loss in men. Calcif Tissue
Int 2001 Oct;69(4):209-13.
10. Gennari L, Brandi ML.
Genetics of male osteoporosis.Calcif Tissue Int 2001

11. Johnell O, Kanis J, Gullberg G.
Mortality, morbidity, and assessment of fracture risk in male
osteoporosis. Calcif Tissue Int 2001 Oct;69(4):182-4.

12. Ishikawa A, Ishikawa S, Hirakawa M.
Osteoporosis, bone turnover and hypogonadism in elderly men
with treated leprosy. Lepr Rev 2001 Sep;72(3):322-9.

13. Seeman E.
Unresolved issues in osteoporosis in men. Rev Endocr Metab
Disord 2001 Jan;2(1):45-64.

14. Ringe JD, Faber H, Dorst A.
Alendronate treatment of established primary osteoporosis in men:
results of a 2-year prospective study. J Clin Endocrinol Metab
2001 Nov;86(11):5252-5.

15. Rogucka E, Jankowska EA, Welon Z, et al.
Bone mineral status of Polish men in the course of normal ageing.
Andrologia 2001 Sep;33(5):287-92.

16. Hattori M, Morita N, Tsujino Y, et al.
Vitamins D and K in the treatment of osteoporosis secondary to
graft-versus-host disease following bone-marrow transplantation. J
Int Med Res 2001 Jul-Aug;29(4):381-4.

17. Tangredi JF, Buxton IL.
Hypertension as a complication of topical testosterone therapy.
Ann Pharmacother 2001 Oct;35(10):1205-7.

18. Tsuruoka S, Nishiki K, Sugimoto K, et al.
Chronotherapy with active vitamin D3 in aged stroke-prone
spontaneously hypertensive rats, a model of osteoporosis. Eur J
Pharmacol 2001 Oct 5;428(2):287-93.

19. Javaid MK, McCrudden PR, Taylor P, et al.
Comparison of calcaneal ultrasound and DXA to assess the risk of
corticosteroid-induced osteoporosis: a cross-sectional study.
Osteoporos Int 2001;12(9):788-93.

20. Xu SZ, Zhou W, Mao XD, et al.
Reference data and predictive diagnostic models for calcaneus
bone mineral density measured with single-energy X-ray
absorptiometry in 7428 Chinese. Osteoporos Int

21. Floreani A, Mega A, Tizian L, et al.
Bone metabolism and gonad function in male patients
undergoing liver transplantation: a two-year longitudinal study.
Osteoporos Int 2001;12(9):749-54.

22. Melton LJ 3rd, Orwoll ES, Wasnich RD.
Does bone density predict fractures comparably in men and
women? Osteoporos Int 2001;12(9):707-9.

23. Grossman JM, MacLean CH.
Quality indicators for the management of osteoporosis in
vulnerable elders. Ann Intern Med 2001 Oct 16;135(8 Pt

24. Wartofsky L.
Update in endocrinology. Ann Intern Med 2001 Oct 16;135(8
Pt 1):601-9.

25. Hindso K, Lauritzen JB.
Osteoporosis and Colles' fracture. Ugeskr Laeger 2001 Oct

26. Seeman E.

Clinical review 137: Sexual dimorphism in skeletal size, density,
and strength. J Clin Endocrinol Metab 2001 Oct;86(10):4576-

27. Lopez-Herce Cid JA, del Castillo Rueda A, Teigell Garcia
L, et al.
Osteoporosis in patients admitted to an internal medicine service
of a university general hospital. An Med Interna 2001

28. Xue Y, Jia W, Zhang H, et al.
Urinary cross-linked N-telopeptides of type I collagen and bone
metabolic diseases. Chin Med J (Engl) 1999 Feb;112(2):149-52.

29. de Vente W, Post GB, Twisk JW, et al.
Effects of health measurements and health information in youth
and young adulthood in dietary intake-20-y study results from
the Amsterdam Growth and Health Longitudinal Study. Eur J
Clin Nutr 2001 Oct;55(10):819-23.

30. James WH.
The bones and hormones of deep water divers and pilots of high
performance aircraft. Occup Environ Med 2001 Oct;58(10):682.

31. Underwood A. II.
Fitness, nutrition, beauty. More veggies, please. Newsweek 2001

32. Adler J, Raymond J. II.
Fitness, nutrition, beauty. Fighting back, with sweat. Newsweek
2001 Fall-Winter;138(11A):34-41.

33. Monteforte P, Molfetta L, Grillo G, et al.
Disodium clodronate in painful nonresponsive periarthropathy of
the hip. Int J Tissue React 2000;22(4):111-5.

34. Springen K. I.
The body, the brain, hormones. Taming raging hormones.
Newsweek 2001 Fall-Winter;138(11A):30-2.

35. Oefelein MG, Ricchuiti V, Conrad W, et al.
Skeletal fracture associated with androgen suppression induced
osteoporosis: the clinical incidence and risk factors for patients
with prostate cancer. J Urol 2001 Nov;166(5):1724-8.

36. Lopez-Ibarra PJ, Pastor MM, Escobar-Jimenez F, et al.
Bone mineral density at time of clinical diagnosis of adult-onset
type 1 diabetes mellitus. Endocr Pract 2001 Sep-Oct;7(5):346-

37. Lunt M, Masaryk P, Scheidt-Nave C, et al.
The effects of lifestyle, dietary dairy intake and diabetes on bone
density and vertebral deformity prevalence: the EVOS study.
Osteoporos Int 2001;12(8):688-98.

38. Murrell P, Todd CJ, Martin A, et al.
Postal administration compared with nurse-supported
administration of the QUALEFFO-41 in a population
sample: comparison of results and assessment of psychometric
properties. Osteoporos Int 2001;12(8):672-9.

39. Juby AG, Davis P.
A prospective evaluation of the awareness, knowledge, risk
factors and current treatment of osteoporosis in a cohort of
elderly subjects. Osteoporos Int 2001;12(8):617-22.

40. Feuerherm AJ, Borset M, Seidel C, et al.
Elevated levels of osteoprotegerin (OPG) and hepatocyte
growth factor (HGF) in rheumatoid arthritis. Scand J
Rheumatol 2001;30(4):229-34.

41. Keller C, Hafstrom I, Svensson B.
Bone mineral density in women and men with early
rheumatoid arthritis. Scand J Rheumatol 2001;30(4):213-

42. Kobayashi I, Kawamura N, Okano M.
A long-term survivor with the immune dysregulation,
polyendocrinopathy, enteropathy, X-linked syndrome. N Engl
J Med 2001 Sep 27;345(13):999-1000.

43. Dawson-Hughes B.
Bone loss accompanying medical therapies. N Engl J Med
2001 Sep 27;345(13):989-91.

44. Rovetta G, Maggiani G, Molfetta L, et al.
One-month follow-up of patients treated by intravenous
clodronate for acute pain induced by osteoporotic vertebral
fracture. Drugs Exp Clin Res 2001;27(2):77-81.

45. Smith MR, McGovern FJ, Zietman AL, et al.
Pamidronate to prevent bone loss during androgendeprivation
therapy for prostate cancer. N Engl J Med 2001
Sep 27;345(13):948-55.

46. Diamond T, Sambrook P, Williamson M, et al.
Guidelines for treatment of osteoporosis in men. Aust Fam
Physician 2001 Aug;30(8):787-91.

47. Diamond T, Sambrook P, Williamson M, et al.
Men and osteoporosis. Aust Fam Physician 2001

48. Melton LJ 3rd, Orwoll ES, Wasnich RD.
Does bone density predict fractures comparably in men and
women? Osteoporos Int 2001;12(9):707-9.

49. Ebeling PR, Wark JD, Yeung S, et al.
Effects of calcitriol or calcium on bone mineral density, bone
turnover, and fractures in men with primary osteoporosis: a
two-year randomized, double blind, double placebo study. J
Clin Endocrinol Metab 2001 Sep;86(9):4098-103.

50. Rizzoli R, Schaad MA, Uebelhart B.
Osteoporosis in men. Nurs Clin North Am 2001
Sep;36(3):467-79, ix.

51. Wang L, Banu J, McMahan CA, et al.
Male rodent model of age-related bone loss in men. Bone
2001 Aug;29(2):141-8.

52. Pande I, Francis RM.
Osteoporosis in men. Best Pract Res Clin Rheumatol 2001

53. Nguyen TV, Maynard LM, Towne B, et al.
Sex differences in bone mass acquisition during growth: the
Fels Longitudinal Study. J Clin Densitom 2001

54. Weber TJ, Drezner MK.
Effect of alendronate on bone mineral density in male
idiopathic osteoporosis. Metabolism 2001 Aug;50(8):912-5.

55. Legrand E, Hedde C, Gallois Y, et al.
Osteoporosis in men: a potential role for the sex hormone
binding globulin. Bone 2001 Jul;29(1):90-5.

56. Huuskonen J, Vaisanen SB, Kroger H, et al.
Regular physical exercise and bone mineral density: a fouryear
controlled randomized trial in middle-aged men. The
DNASCO study. Osteoporos Int 2001;12(5):349-55.

57. Orwoll E, Ettinger M, Weiss S, et al.
Alendronate for the treatment of osteoporosis in men.
N Engl J Med 2000 Aug 31;343(9):604-10.

58. Rovetta G, Monteforte P, Balestra V.
Intravenous clodronate for acute pain induced by osteoporotic
vertebral fracture. Drugs Exp Clin Res 2000;26(1):25-30.



©2002     free web templates at